Search Results for: "Other News to Note"
-
Other News To Note
The PDUFA date is set for SeptBioWorld Today | Friday, May 24, 2013 -
Other News To Note
Pursuant to the agreement, the company may from time to time sell up to a maximum of $20 million of the company's American Depositary Shares (ADSsBioWorld International | Wednesday, May 22, 2013 -
Other News To Note
The drug's PDUFA date is Aug. 26BioWorld Today | Monday, May 20, 2013 -
Other News To Note
Earlier this month, Alimera resubmitted the new drug application for Iluvien, which has a PDUFA date of Oct. 17BioWorld Today | Thursday, May 9, 2013 -
Other News To Note
QRxPharma Ltd., of Sydney, Australia, said the FDA set a PDUFA date of Aug. 26 for the resubmitted new drug application seeking approval of Moxduo, an immediate-release dual opioid pain therapy that combines morphine and oxycodoneBioWorld International | Wednesday, March 20, 2013 -
Other News To Note
QRxPharma Ltd., of Sydney, Australia, said the FDA set a PDUFA date of Aug. 26 for the resubmitted new drug application seeking approval of Moxduo, an immediate-release dual opioid pain therapy that combines morphine and oxycodoneBioWorld Today | Friday, March 15, 2013 -
Other News To Note
The PDUFA date for the sNDA is Oct. 21BioWorld Today | Thursday, March 7, 2013 -
Other News To Note
The PDUFA date for tivozanib, a once-daily, VEGF receptor tyrosine kinase inhibitor, is July 28. (See BioWorld Today, Jan. 4, 2012, and Aug. 6, 2012...Titan submitted the application in October under the 505(b)(2) pathway, and the NDA was granted priority review, with a PDUFA date of April 30BioWorld Today | Thursday, February 28, 2013 -
Other News To Note
The FDA classified the resubmission as a complete, Class 1 response to its October 2012 complete response letter and set a PDUFA date of March 31BioWorld Today | Friday, February 15, 2013 -
Pharma: Other News To Note
The PDUFA date is April 29BioWorld Today | Tuesday, January 29, 2013 -
Other News To Note
The PDUFA date will be in the third quarter of this year...QRxPharma Ltd., of Sydney, Australia, said it clarified the steps necessary with the FDA for approval of pain candidate MoxDuo, with a new drug application resubmission expected this quarter and a new PDUFA date set for the third quarterBioWorld International | Wednesday, January 23, 2013 -
Other News To Note
Hyperion Therapeutics Inc., of South San Francisco, said the FDA advised the company not to expect a final action on its new drug application (NDA) for Ravicti (glycerol phenylbutyrate) by the PDUFA date of Jan. 23...In September, the FDA extended the PDUFA date for its review of Ravicti by three months, citing the need to provide time for a full review of the submissionBioWorld Today | Thursday, January 17, 2013 -
Other News To Note
The PDUFA date for canagliflozin is May 31BioWorld International | Wednesday, January 16, 2013 -
Pharma: Other News To Note
The PDUFA date will be in the third quarter of this yearBioWorld Today | Wednesday, January 16, 2013 -
Pharma: Other News To Note
The PDUFA date for canagliflozin is May 31BioWorld Today | Monday, January 14, 2013 -
Other News To Note
The drug gained the FDA's blessing late last month, a few days ahead of its PDUFA date, as a long-term treatment for short bowel syndrome (SBS), an ultra-orphan indicationBioWorld Today | Friday, January 4, 2013 -
Other News To Note
The PDUFA date is April 30BioWorld Today | Thursday, January 3, 2013 -
Pharma: Other News To Note
Its PDUFA date is March 17, 2013BioWorld Today | Thursday, December 27, 2012 -
Other News To Note
Although committee votes are nonbinding, CDER will consider them in making a final determination on the synthetic, double-stranded RNA compound, which has a PDUFA date of Feb. 2, 2013BioWorld Today | Wednesday, December 19, 2012 -
Other News To Note
The PDUFA date is Oct. 3, 2013BioWorld Today | Monday, December 17, 2012
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.